Scarica l'app Stockscreener
2.60
4.42%
0.11
Dopo l'orario di chiusura:
2.66
0.06
+2.31%
Precedente Chiudi:
$2.49
Aprire:
$2.45
Volume 24 ore:
546.82K
Relative Volume:
0.42
Capitalizzazione di mercato:
$24.15M
Reddito:
-
Utile/perdita netta:
$-45.57M
Rapporto P/E:
-0.4127
EPS:
-6.3
Flusso di cassa netto:
$-38.56M
1 W Prestazione:
-8.45%
1M Prestazione:
+44.44%
6M Prestazione:
-36.59%
1 anno Prestazione:
-10.65%
Intervallo 1D:
$2.43
$2.85
Intervallo di 1 settimana:
$2.245
$6.60
Portata 52W:
$1.00
$6.60
Sab Biotherapeutics Inc Stock (SABS) Company Profile
Nome
Sab Biotherapeutics Inc
Settore
Industria
Telefono
305-845-2813
Indirizzo
777 W 41ST ST, MIAMI BEACH
Confronta SABS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SABS
Sab Biotherapeutics Inc
|
2.60 | 23.13M | 0 | -45.57M | -38.56M | -6.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Sab Biotherapeutics Inc Stock (SABS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-14 | Ripresa | H.C. Wainwright | Buy |
| 2024-10-09 | Iniziato | Craig Hallum | Buy |
| 2024-08-28 | Iniziato | Oppenheimer | Outperform |
| 2021-11-05 | Iniziato | Chardan Capital Markets | Buy |
Sab Biotherapeutics Inc Borsa (SABS) Ultime notizie
How SAB Biotherapeutics Inc. Equity Warrant stock reacts to Fed policy changesMarket-beating performance - jammulinksnews.com
How SAB Biotherapeutics Inc. stock reacts to Fed policy changesExceptional market positioning - jammulinksnews.com
SAB Biotherapeutics Shares Jump 33% After Securing $175M in Oversubscribed Private Placement - MSN
What analysts say about SAB Biotherapeutics Inc. stockFree Expert Stock Watchlist - Autocar Professional
Is SAB Biotherapeutics Inc. a good long term investmentHigh-performance investment picks - Autocar Professional
Is SAB Biotherapeutics Inc. Equity Warrant a good long term investmentFree Wealth Planning Blueprint - jammulinksnews.com
SAB Biotherapeutics Inc. Stock Analysis and ForecastExplosive returns - Autocar Professional
SAB Biotherapeutics Plunges 10.34% on Private Placement Concerns - AInvest
What drives SAB Biotherapeutics Inc. stock priceMarket-beating performance - jammulinksnews.com
What drives SAB Biotherapeutics Inc. Equity Warrant stock priceBreakthrough profit margins - jammulinksnews.com
What analysts say about SAB Biotherapeutics Inc. Equity Warrant stockExceptional financial outcomes - jammulinksnews.com
SAB Biotherapeutics Inc. Equity Warrant Stock Analysis and ForecastExplosive trading growth - jammulinksnews.com
SAB Biotherapeutics stock price target lowered to $9 by H.C. Wainwright - Investing.com Canada
SAB Biotherapeutics Stock Surges 5.06% to Rank 277th in Trading Volume - AInvest
SAB Biotherapeutics stock price target raised to $14 from $12 at Oppenheimer - Investing.com Canada
SAB Biotherapeutics Inc (SABS) Stock: A Year of Market Movement, Down and Up - investchronicle.com
SABS Soars 24.5% on Volatile Intraday Surge—What’s Fueling the Biotech Rally? - AInvest
SAB Biotherapeutics (SABS) up more than 100% since Jun 30 - AInvest
SABS Surges 42%—Volatile Rally Reaches 52-Week High Amid Market Turbulence - AInvest
Sab Biotherapeutics shares rise 144.48% intraday after raising $175 million in private placement. - AInvest
SAB Biotherapeutics Stock Surge: Should You Buy? - StocksToTrade
SAB Biotherapeutics stock soars after securing $175 million private placement By Investing.com - Investing.com Nigeria
SAB Biotherapeutics stock soars after securing $175 million private placement - Investing.com India
SAB BIO Stock Explodes 54% on Game-Changing $175 Million Private Placement Deal - RagingBull
SAB Biotherapeutics Secures $175M in Private Placement - TipRanks
SAB Biotherapeutics announces oversubscribed $175M private placement - TipRanks
SAB BIO Announces Oversubscribed $175 Million Private Placement - GlobeNewswire
SAB BIO Secures $175M Funding Led by Sanofi to Advance Revolutionary Type 1 Diabetes Treatment Through 2028 - Stock Titan
SABS Stock on the Rise: What’s Next? - timothysykes.com
Published on: 2025-07-20 20:52:24 - jammulinksnews.com
Sab Biotherapeutics Inc Azioni (SABS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):